Medtronic Neurovascular has a new chief medical officer
Medtronic (NYSE: MDT)+ announced today that it appointed Dr. Adam S. Arthur as chief medical officer for its Neurovascular business.
Medtronic (NYSE: MDT)+ announced today that it appointed Dr. Adam S. Arthur as chief medical officer for its Neurovascular business.